if it was Tyrian that terminated the agreement due to the slow sales from Bayer....then TDX may well have a valid claim. If Bayer were given some sales hurdles to achieve as part of the agreement, which they accepted, and TDX then invested in developing the whole supply chain to meet those hurdles then TDX would need to be compensated for that investment. I suppose this is a question for the AGM
Ann: Annual Report to shareholders , page-13
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add APL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.908M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3167 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 19131 | 1 |
View Market Depth
| Last trade - 16.12pm 27/09/2024 (20 minute delay) ? |
| APL (ASX) Chart |
Day chart unavailable